Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$78.78
-1.67-2.08%
Last update: Oct 14, 2:00 PM
$81.10
0.650.81%
Spyre Therapeutics Inc (SYRE) Stock Price, Quote, News & History
SYRENASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Other companies in Spyre Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Spyre Therapeutics has a consensus price target of $100.88.
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $78.78 last updated October 14, 2026 at 2:00 PM EDT.
There are no upcoming dividends for Spyre Therapeutics.
Spyre Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Spyre Therapeutics.
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
